Showing results (11-20 of 196) with videos related to
Sort By:
Pageof 20
Food and Drug Law Journal|December 17, 2009
Obesity, fast food manufacture, and regulation: revisiting opportunities for reformHaitham M AhmedFood and Drug Law Journal|December 17, 2009
FDA's expanding postmarket authority to monitor and publicize food and consumer health product risks: the need for procedural safeguards to reduce "transparency" policy harms in the post-9/11 regulatory environmentSarah Taylor Roller, Raqiyyah R Pippins, Jennifer W NgaiFood and Drug Law Journal|November 16, 2017
Truth, Falsity, and Fraud: Off-Label Drug Settlements and the Future of the Civil False Claims ActJoan H KrauseFood and Drug Law Journal|November 16, 2017
Sunlight and Other Disinfectants: Disclosure Obligations under the Federal Securities and Drug Regulatory RegimesJoseph G MilnerFood and Drug Law Journal|July 8, 2016
Substantial Equivalence Premarket Review: the Right Approach for Most Medical DevicesJeffrey K ShapiroFood and Drug Law Journal|February 5, 2002
Medical device labeling and advertising: an overviewE M Basile, E Armentrout, K N ReevesFood and Drug Law Journal|January 25, 2002
How should FDA regulate prescription drug promotion on the Internet?D W OpderbeckFood and Drug Law Journal|January 19, 2002
Kickbacks, courtesies or cost-effectiveness?: Application of the Medicare antikickback Law to the marketing and promotional practices of drug and medical device manufacturersT N Bulleit, J H KrauseFood and Drug Law Journal|March 14, 2014
The Food Safety Modernization Act: a barrier to trade? Only if the science says soNaomi McNeillFood and Drug Law Journal|February 1, 2014
Global regulatory standards for the approval of biosimilarsBarbara Mounho, Audrey Phillips, Kay Holcombe, et al.Pageof 20